Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/19/2013WO2013052771A3 Personal care compositions and methods of making same
12/19/2013WO2013050625A8 Antiviral efficacy of disodium 2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) and its derivatives
12/19/2013WO2003057278A3 Drug delivery system for sustained delivery of glipizide
12/19/2013US20130338645 Transdermal drug delivery method and system
12/19/2013US20130338574 Oral medicinal composition for patients undergoing peritoneal dialysis and method for using same
12/19/2013US20130338569 Polymeric hydrogel compositions which release active agents in response to electrical stimulus
12/19/2013US20130338236 Sanitizer compositions comprising alcohol and an antimicrobial efficacy enhancer
12/19/2013US20130338235 Dermatological foams obtained from a gel or suspension containing benzoyl peroxide
12/19/2013US20130338234 Method for direct extraction and concentration of naturally-derived active compounds
12/19/2013US20130338232 Method of reducing brain cell damage, inflammation or death
12/19/2013US20130338230 Dermatological foams obtained from a gel or suspension containing adapalene
12/19/2013US20130338228 Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
12/19/2013US20130338226 Ingenols for treating seborrheic keratosis
12/19/2013US20130338225 Compounds As L-Cystine Crystallization Inhibitors And Uses Thereof
12/19/2013US20130338220 Compositions, dosages, and methods of using tetrahydrocannabinol derivatives
12/19/2013US20130338217 Antibiotic composition including phlorotannin compound derived from eisenia bicyclis as effective component
12/19/2013US20130338213 RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS
12/19/2013US20130338210 Compositions for nucleic acid delivery
12/19/2013US20130338209 Treatment for lipodystrophy
12/19/2013US20130338207 Carbazole formulations for the treatment of psoriasis and angiogenesis
12/19/2013US20130338206 Topical liquid to ameliorate pain and promote healing of burn-injured skin
12/19/2013US20130338205 Bendamustine pharmaceutical compositions
12/19/2013US20130338203 TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
12/19/2013US20130338201 Method of Cancer Treatment with 2-(1H-Indole-3-Carbonyl)-Thiazole-4-Carboxylic Acid Methyl Ester
12/19/2013US20130338200 Pharmaceutical dosage forms of tizanidine and administration routes thereof
12/19/2013US20130338198 Composition for treating dermatitis and ichthyosis, and method for treating dermatitis and ichthyosis
12/19/2013US20130338196 Alpha-ketoheterocycles and methods of making and using
12/19/2013US20130338192 Method for augmenting the effects of serotonin reuptake inhibitors
12/19/2013US20130338189 Crystal of anti-bacterial compound
12/19/2013US20130338188 Pharmaceutical compositions and administrations thereof
12/19/2013US20130338186 Amides of acetic and propionic acids
12/19/2013US20130338185 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
12/19/2013US20130338183 Compositions and methods for mobilizing stem cells
12/19/2013US20130338181 Treatment of effect of chemicals with their ultradilute stereoisomers
12/19/2013US20130338180 Formulation comprising phenylaminopyrimidine derivative as active agent
12/19/2013US20130338178 Sirtuin modulators as inhibitors of cytomegalovirus
12/19/2013US20130338176 Methods of preventing and treating hyperlipidemia or atherosclerosis
12/19/2013US20130338172 Crystalline forms of a bruton's tyrosine kinase inhibitor
12/19/2013US20130338171 Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties
12/19/2013US20130338168 Combinations of JAK Inhibitors
12/19/2013US20130338166 Reducing side effects of tramadol
12/19/2013US20130338165 Use of Compounds Elevating Glutathione Levels for the Treatment of Parkinson's Disease
12/19/2013US20130338163 Vinyl-aryl derivatives for inflammation and immune-related uses
12/19/2013US20130338161 Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
12/19/2013US20130338159 Bi-heteroaryl compounds as vps34 inhibitors
12/19/2013US20130338155 Method for treating infections
12/19/2013US20130338154 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
12/19/2013US20130338152 Fluorophenyl bicyclic heteroaryl compounds
12/19/2013US20130338151 Fused ring analogues of anti-fibrotic agents
12/19/2013US20130338149 Sedative for use during eye surgery
12/19/2013US20130338148 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
12/19/2013US20130338145 Method for Mediating Dopamine Receptor-Driven Reacidification of Lysosomal pH
12/19/2013US20130338140 Serine/threonine kinase inhibitors
12/19/2013US20130338138 Azetidine and piperidine compounds useful as pde10 inhibitors
12/19/2013US20130338137 Substituted annellated pyrimidines and use thereof
12/19/2013US20130338133 Substituted imidazopyridazines
12/19/2013US20130338132 Heteroarylcarboxylic acid ester derivative
12/19/2013US20130338130 Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms
12/19/2013US20130338129 Method of treating refractory cancer
12/19/2013US20130338127 Triamcinolone acetonide formulations for treating dermatitis and psoriasis
12/19/2013US20130338126 Ophthalmic Suspension for Ocular Use
12/19/2013US20130338125 Treatment methods using pharmaceutical solid state forms
12/19/2013US20130338124 Organic compounds
12/19/2013US20130338123 Natural combination hormone replacement formulations and therapies
12/19/2013US20130338122 Transdermal hormone replacement therapies
12/19/2013US20130338121 Two speed monolithic system for controlled release of drugs
12/19/2013US20130338117 Therapeutic compounds for blocking dna synthesis of pox viruses
12/19/2013US20130338116 Compounds and methods for the treatment of pain and other diseases
12/19/2013US20130338115 Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
12/19/2013US20130338114 Compositions for increasing strength, muscle mass, and lean body mass
12/19/2013US20130338113 Materials and methods for treating viral infections
12/19/2013US20130338111 Sulfonamide Derivatives
12/19/2013US20130338102 Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
12/19/2013US20130338101 Cell-adhesive, enzymatically crosslinked flavonoid hydrogels and methods for making same
12/19/2013US20130338100 Method of Cross-Linking Hyaluronic Acid with Divinylsulfone
12/19/2013US20130338099 Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof
12/19/2013US20130338098 Topical Analgesic Compositions Containing Aliphatic Polyamines and Methods of Using Same
12/19/2013US20130338097 Histone inhibition
12/19/2013US20130338093 Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
12/19/2013US20130338092 Compounds and methods for targeting leukemic stem cells
12/19/2013US20130338088 Self solidifying bioerodible barrier implant
12/19/2013US20130338087 Pharmaceutical formulations
12/19/2013US20130338079 Treatment of primary and metastatic carcinoma
12/19/2013US20130338073 Durable haemostatic scaffold
12/19/2013US20130338072 Methods for treating organs
12/19/2013US20130338066 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
12/19/2013US20130338058 Use of lipid conjugates in the treatment of conjunctivitis
12/19/2013US20130337096 Chewable vehicle for mouth absorption
12/19/2013US20130337092 Phytonutrient compositions and methods of use
12/19/2013US20130337091 Pharmaceutical use
12/19/2013US20130337088 Methods for treating scars and aging skin
12/19/2013US20130337086 Mineral salt-sulfonic acid compositions and methods of use
12/19/2013US20130337077 Nanospheres for therapeutic agent delivery
12/19/2013US20130337074 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis
12/19/2013US20130337070 Coated Nanoparticle Therapy for Skin Cancer
12/19/2013US20130337065 Aptamer bioconjugate drug delivery device
12/19/2013US20130337063 Pharmaceutical compositions of maraviroc and process for the preparation thereof
12/19/2013US20130337061 Pharmaceutical compositions for sleep apnea
12/19/2013US20130337060 Oral Pharmaceutical Dosage Forms
12/19/2013US20130337059 Oral Pharmaceutical Dosage Forms
1 ... 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 ... 7860